Genetic vulnerability to drug abuse

European Psychiatry

Volumn 15, Issue 2, 2000, Pages 109-114

  Duaux, E ^a   Krebs, M O ^a   Loo, H ^a   Poirier, M F ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Addiction; Allele; Association; Drug abuse; Genetics; Polymorphism

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CANNABIS; COCAINE; DIAMORPHINE; DOPAMINE RECEPTOR; OPIATE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT; SEROTONIN;

ADDICTION; ALLELE; ARTICLE; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; FAMILY STUDY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0034113878     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(00)00204-2     Document Type: Article

References (47)

1. Benjamin J., Li L., Patterson C., Greenberg B.G., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Gen. 12:1996;81-84.
2. Berrettini W.H., Persico A.M. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiatry. 40:1996;144-147.
3. Blum K., Sheridan P., Wood R., Bracermann E., Chen T., Comings D. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 5:1995;121-141.
4. Bond C., Laforge K., Tian M., Melia D., Zhang S., Borg L., et al. Single-nucleotide polymorphism in the human mu opiod receptor gene alters betaendorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA. 95:1998;9608-9613.
5. Cadoret R.J., Troughton E., O'Gorman T.W., Heywood E. An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry. 43:1986;1131-1136.
6. Cadoret R.J., Yates W.R., Troughton E., Woodworth G., Stewart M.A. Adoption studies demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry. 52:1995;42-52.
7. Chaudry H., Arria A., Tarter R., Chaudhry S., Chaudhry N. Familial history of opium use and reported problems among opium addicts in Pakistan. Br J Addicts. 86:1991;785-788.
8. Comings D.E., Gade R., Muhleman D., Chiu C., Wu S., To M., et al. Exon and intron variants in the human tryptophan 2, 3 dioxygenase gene: potential association with Tourette's syndrome, substance abuse and other disorders. Pharmacogenetics. 4:1996;307-318.
9. Comings D.E., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 2:1997;44-56.
10. Comings D.E., Muhleman D., Ahn C., Gysin R., Flanagan S. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend. 34:1994;175-180.
11. Comings D.E., Muhleman D., Gade R., Johnson P., Verde R., Saucier G., et al. Cannabinoid receptor gene (CNR1): association with IV drug use. Mol Psychiatry. 2:1997;161-168.
12. Duaux E., Laplanche P., Gorwood P., Bourdel M.C., Launay J.M., Poirier M.F. Role of the serotonin transporter promoter polymorphism, opiate dependence and suicide attempts. Communication at the IBANGS Meeting, Key Largo. Oct 1999.
13. Ebstein R.P., Gritsenko I., Nemanov L., Frish A., Osher Y., Belmaker R.H. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry. 2:1997;224-226.
14. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., et al. Dopamine D4 receptor exon III polymorphism associated with the human personality trait of novelty seeking. Nat Gen. 12:1996;78-84.
15. Edenberg H.J., Reynolds J., Koller D.L., Begleiter H., Bucholz K.K., Conneally P.M., et al. A family-ased analysis of whether the functional promoter alleles of the serotonin transporter gene 5-HTT affect the risk for alcohol dependence. Alcohol Clin Exp Res. 22:1998;1080-1085.
16. Freimer M., Kranzler H., Satel S., Lacobelle J., Skipsey K., Charney D., et al. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict Biol. 1:1996;281-287.
17. Gebhardt C., Füreder T., Fuchs K., Urmann A., Stompe T., Fathi N., et al. No association of novelty seeking with DRD2 and DRD3 receptor gene polymorphims [abstract]. Am J Med Gen. 81:1998;497.
18. Gelernter J., Kranzler H., Cubells J. Genetic of two opiod receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependence subjects. Mol Psychiatry. 4:1999;476-483.
19. Gelernter J., Kranzler H., Satel S.L. No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of coccaine dependence in European- and African-Americans. Biol Psychiatry. 45:1999;340-345.
20. Golberg J., Lyons M.J., Eisen S.A., True W.R., Tsuang M. Genetic influence on drug use: a preliminary analysis of 2, 674 Vietnam-era veteran twins [abstract]. Behav Genet. 552:1993.
21. Gorwood P., Batel P., Ades J., Hamon M., Boni C. Serotonin transporter gene polymorphisms, alcoholism and suicidal behaviour. Biol Psychiatry. in press.
22. Grove W.M., Eckert E.D., Heston L., Bouchard T.J., Segal N., Lykken D.T. Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry. 27:1990;1293-1304.
23. Hallikainen T., Saito T., Lachman H.M., Volavka J., Pohjalainen T., Ryynänen, et al. Association between low activity serototnin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry. 4:1999;385-388.
24. Helzer J.E., Burman A., McEvoy L.T. Alcohol abuse and dependence. Regier A.D, Robins L.N. Psychiatric disorders in America. The Epidemiolog Catchment Area Study. 1991;81-115 Free Press; New York.
25. Jorm A.F., Henderson A.S., Jacomb P.A., Christensen H., Korten A.E., Rodgers B., et al. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry. 3:1998;449-451.
26. Kendler K.S., Karkowski L., Prescott C.A. Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins. Acta Psychiatr Scand. 5:1999;368-376.
27. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulemberg J., Anthony J.C., et al. Lifetime co-occurence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 54:1997;313-321.
28. Kotler M., Cohen H., Kremer I., Mel H., Horowitz R., Ohel N., et al. No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (Bal I D3DR) polymorphisms and heroin addiction. Mol Psychiatry. 4:1999;313-316.
29. Kotler M., Cohen H., Segman R., Gritsenko I., Nemanov L., Lere B., et al. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry. 2:1997;251-254.
30. Kranzler H., Gelernter J., O'Malley, Hernandezavila C., Kaufman D. Association of alcohol or other drug dependence with alleles of the mu opiod receptor gene (OPMR1). Alcohol Clin Exp Res. 22:1998;1359-1362.
31. Li T., Xu K., Deng H., Cai G., Liu J., Wang R., et al. Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry. 2:1997;413-416.
32. Luthar S.S., Anton S.F., Merikangas K.R., Rounsaville B.J. Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis. 180:1992;153-161.
33. Malhotra A.K., Virkkunen M., Rooney W., Eggert M., Linnoila M., Goldman D. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry. 1:1996;388-391.
34. Mayer P., Rochlitz H., Rauch E., Rommelsacher H., Hasse H.E., Schmidt S., Hollt V. Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport. 8:1997;2547-2550.
35. Merikangas K.R., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., et al. Familial transmission of substance use disorders. Arch Gen Psychiatry. 55:1998;973-979.
36. Miller N.S., Gold M.S., Belkin B.M., Klahr A.L. The diagnosis of alcohol and cannabis dependence in cocaine dependents and alcohol dependence in their families. Br J Addict. 84:1993;1491-1498.
37. Mirin S.M., Weiss R.D., Griffin M.L., Michael J.L. Psychopathology in drugs abusers and their families. Compr Psychiatry. 32:1991;36-51.
38. Noble E.P., Blum K., Khalsa M.E., Ritchie T., Montgomery A., Wood R.C., et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend. 33:1993;271-285.
39. O'Hara B.F., Smith S.S., Bird G., Persico A.M., Suarez B.K., Cutting G.R., et al. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Her. 43:1993;209-218.
40. Ono Y., Manki H., Yoshimura K., Muramatsu T., Mizushima H., Higuchi S., et al. Association between dopamine D4 receptor (DRD4) exon III polymorphism and novelty seeking in Japanese subjects. Am J Med Gen. 74:1997;501-503.
41. Pickens R.W., Svikis D.S. Genetic influences in human substance abuse. Arch Gen Psychiatry. 10:1991;202-213.
42. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 264:1990;2511-2518.
43. Rounsaville B.J., Kosten T.R., Weissman M.M.P., Pauls D., Anton S.F., Merikangas K. Psychiatric disorders in the relatives of probands with opiate addiction. Arch Gen Psychiatry. 488:1991;33-42.
44. Sander T., Harms H., Dufeu P., Kuhn S., Hoehe M., Lesh K.P., et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry. 43:1998;908-912.
45. Smith S.S., O'Hara B.F., Persico A.M., Gorelick M.A., Newlin D.B., Vlahov D., et al. Genetic vulnerability to drug abuse, the D2 dopamine receptor Taq 1 B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 49:1992;723-727.
46. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., et al. Co-occurence of abuse of different drugs in men, the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 55:1998;967-972.
47. Vandenbergh D.J., Zonderman A.B., Wang J., Uhl G.R., Costa P.T. No association between novelty seeking and dopamine D4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants. Mol Psychiatry. 2:1997;417-419.